Bryn Mawr Trust CO Novo Cure LTD Transaction History
Bryn Mawr Trust CO
- $5.48 Billion
- Q3 2024
A detailed history of Bryn Mawr Trust CO transactions in Novo Cure LTD stock. As of the latest transaction made, Bryn Mawr Trust CO holds 361 shares of NVCR stock, worth $9,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
361Holding current value
$9,505% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
76.9MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$319 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$312 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$209 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$113 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$79.8 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.76B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...